These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19169753)

  • 21. [Cancer of the urinary bladder: prognosis of the outcome].
    Zimichev AA; Prianichnikova MB; Maklakov VN
    Urologiia; 2009; (3):52-3. PubMed ID: 19673123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic influence of sub-stages according to pTNM categories in patients with stage IV gastric cancer.
    Li C; Yan M; Chen J; Xiang M; Zhu ZG; Lin YZ
    J Surg Oncol; 2009 May; 99(6):324-8. PubMed ID: 19204941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of recurrence of early gastric cancer after curative resection.
    Lai JF; Kim S; Kim K; Li C; Oh SJ; Hyung WJ; Rha SY; Chung HC; Choi SH; Wang LB; Noh SH
    Ann Surg Oncol; 2009 Jul; 16(7):1896-902. PubMed ID: 19434457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis.
    Busuttil RA; Boussioutas A
    J Gastroenterol Hepatol; 2009 Feb; 24(2):193-201. PubMed ID: 19215332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The prognostic relevance of age and comorbidity in patients with resected gastric cancer].
    Bollschweiler E; Breckheimer S; Mönig SP; Hölscher AH
    Zentralbl Chir; 2009 Feb; 134(1):71-6. PubMed ID: 19242886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival benefit of pylorus-preserving gastrectomy in early gastric cancer.
    Hiki N; Sano T; Fukunaga T; Ohyama S; Tokunaga M; Yamaguchi T
    J Am Coll Surg; 2009 Sep; 209(3):297-301. PubMed ID: 19717032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer.
    Vidal O; Metges JP; Elizalde I; Valentíni M; Volant A; Molina R; Castells A; Pera M
    Br J Surg; 2009 Dec; 96(12):1443-51. PubMed ID: 19918848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of super-extended (D3) lymphadenectomy in gastric cancer surgery.
    Laterza E; Giacopuzzi S; Minicozzi A; Saladino E; de Manzoni G
    Ann Ital Chir; 2009; 80(2):101-6. PubMed ID: 19681290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma.
    Song KY; Jung CK; Park WS; Park CH
    Jpn J Clin Oncol; 2009 May; 39(5):290-6. PubMed ID: 19336448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different pathological features and prognosis in gastric cancer patients coming from high-risk and low-risk areas of Italy.
    Marrelli D; Pedrazzani C; Corso G; Neri A; Di Martino M; Pinto E; Roviello F
    Ann Surg; 2009 Jul; 250(1):43-50. PubMed ID: 19561483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II trial of endoscopic submucosal dissection for mucosal gastric cancer: Japan Clinical Oncology Group Study JCOG0607.
    Kurokawa Y; Hasuike N; Ono H; Boku N; Fukuda H;
    Jpn J Clin Oncol; 2009 Jul; 39(7):464-6. PubMed ID: 19493869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic index reflecting genetic alteration related to disease-free time for gastric cancer patient.
    Kim M; Rha SY
    Oncol Rep; 2009 Aug; 22(2):421-31. PubMed ID: 19578786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetics of breast cancer: toward the individualization of therapy.
    Chang JC; Hilsenbeck SG; Fuqua SA
    Cancer Invest; 2009 Aug; 27(7):699-703. PubMed ID: 19637041
    [No Abstract]   [Full Text] [Related]  

  • 35. Correlation of microsatellite instability at multiple loci with long-term survival in advanced gastric carcinoma.
    Corso G; Pedrazzani C; Marrelli D; Pascale V; Pinto E; Roviello F
    Arch Surg; 2009 Aug; 144(8):722-7. PubMed ID: 19687375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric cancer: the correlation between the clinicopathological factors and patients' survival (I).
    Lazăr D; Tăban S; Dema A; Cornianu M; Goldiş A; Raţiu I; Sporea I
    Rom J Morphol Embryol; 2009; 50(1):41-50. PubMed ID: 19221644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
    Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
    Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric cancer: correlation between clinicopathological factors and survival of patients. II.
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2009; 50(2):185-94. PubMed ID: 19434309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Assessment of oncologic risk of breast reconstruction simultaneous with surgery for breast cancer].
    Portnoĭ SM; Blokhin SN; Arslanov KhS; Laktionov KP; Balakireva GV; Akhmetov MSh
    Vopr Onkol; 2008; 54(6):720-3. PubMed ID: 19241846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.